CA19-9 decrease and overall survival (OS) in the NAPOLI-1 trial of liposomal irinotecan (nal-IRI) ± 5-fluorouracil and leucovorin (5-FU/LV) in metastatic pancreatic ductal adenocarcinoma (mPDAC) previously treated with gemcitabine-based therapy

  • Li Tzong Chen
  • , Andrea Wang-Gillam
  • , Yan Shen Shan
  • , Teresa Macarulla
  • , Jean Frédéric Blanc
  • , Richard Hubner
  • , Chang Fang Chiu
  • , Gilberto Schwartsmann
  • , Jens Siveke
  • , Pipas J. Marc
  • , Bruce Belanger
  • , Floris de Jong
  • , Khalid Mamlouk
  • , Daniel Von Hoff

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)iii6-iii7
JournalAnnals of oncology : official journal of the European Society for Medical Oncology
Volume28
DOIs
Publication statusPublished - 2017 Jun 1

All Science Journal Classification (ASJC) codes

  • Hematology
  • Oncology

Cite this